News Author: Patrice Wendling Publish date: February 6, 2016
Key clinical point: The risk of end-stage renal disease in lupus nephritis decreased from the 1970s to the mid-1990s but has since remained largel...
News Author: Patrice Wendling Publish date: February 5, 2016
Key clinical point: Pulsed electromagnetic fields therapy is safe and effective in improving knee osteoarthritis symptoms.
Major finding: The mean...
News Author: Patrice Wendling Publish date: February 3, 2016
In obese pregnant women without diabetes, daily metformin reduces maternal weight gain, but not infant birth weight, results of the MOP trial show. Th...
News Author: Patrice Wendling Publish date: February 2, 2016
Nearly 30% of outpatient colonoscopies for colon cancer screening or polyp surveillance were preceded by a gastroenterology office visit, with that nu...
News Author: Patrice Wendling Publish date: January 23, 2016
Key clinical point: The presence of minimal residual disease provides powerful prognostic information independent of other risk factors in patient...
News Author: Patrice Wendling Publish date: January 21, 2016
Key clinical point: Non-invasive radiomics is showing potential for reducing false positives by differentiating between benign and cancerous lung ...
Article Author: Patrice Wendling Publish date: January 20, 2016
News Author: Patrice Wendling Publish date: January 19, 2016
Advances in microsurgery technique have made lymphovenous bypass (LVB) and lymph node transfer (LNT) increasingly feasible as treatment for lymphedema...
News Author: Patrice Wendling Publish date: January 16, 2016
News Author: Patrice Wendling Publish date: January 16, 2016
News Author: Patrice Wendling Publish date: January 13, 2016
Experts at the FDA/ASH symposium shed light on use of the three newly approved agents daratumumab, ixazomib, and elotuzumab.
News Author: Patrice Wendling Publish date: January 11, 2016
News Author: Patrice Wendling Publish date: December 29, 2015
Key clinical point: Initial results show promising activity for pembrolizumab in combination with lenalidomide and low-dose dexamethasone in heavi...
News Author: Patrice Wendling Publish date: December 20, 2015
Video Author: Patrice Wendling Publish date: December 17, 2015
Key clinical point: The first clinical trial of a CAR targeting BCMA demonstrated strong antimyeloma activity in patients with at least 3 prior l...
